After row, Bharat Biotech scraps Brazil Covaxin deal

Bharat Biotech, the developer of indigenous Covid-19 vaccine Covaxin, on Friday said it has terminated, with immediate effect, its MoU dated November 24, 2020, with its Brazilian partners for Covaxin — Precisa Medicamantos and Envixia Pharmaceuticals LLC.

After row, Bharat Biotech scraps Brazil Covaxin deal
Bharat Biotech, the developer of indigenous Covid-19 vaccine Covaxin, on Friday said it has terminated, with immediate effect, its MoU dated November 24, 2020, with its Brazilian partners for Covaxin — Precisa Medicamantos and Envixia Pharmaceuticals LLC.